Trial
NCT05481112
Assessing Optimal XR-Buprenorphine Initiation Points in Jail
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
NYU Langone Health
Collaborators
National Institute on Drug Abuse (NIDA)
Condition
Opioid Use Disorder
Intervention
Extended-Release Buprenorphine Injection
Why stopped
This study was not initiated due to policy changes in Massachusetts (the proposed study sites).
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-29